Genetic background influences adaptation to cardiac hypertrophy and Ca2+ handling gene expression

Frontiers in Physiology

Volumn 4 MAR, Issue , 2013, Pages

  Waters, Steve B ^a   Diak, Douglass M ^a   Zuckermann, Matthew ^a   Goldspink, Paul H ^b   Leoni, Lara ^a   Roman, Brian B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Ca2+ handling; Gene expression; Heart; Hemodynamics; Hypertrophy; Mouse

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CREATINE KINASE BB; DOBUTAMINE; ISOPRENALINE; MESSENGER RNA; PHOSPHOLAMBAN; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

129 MOUSE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSOL; GENE EXPRESSION; HEART HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; STRAIN DIFFERENCE; UPREGULATION;

EID: 84883829630     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00011     Document Type: Article

References (31)

1. Barrick, C. J., Rojas, M., Schoonhoven, R., Smyth, S. S., and Threadgill, D. W. (2007). Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 292, H2119-H2130.
2. Barry, W. H., and Bridge, J. H. (1993). Intracellular calcium homeostasis in cardiac myocytes. Circulation 87, 1806-1815.
3. Bleumink, G. S., Schut, A. F. C., Sturkenboom, M. C. J. M., Deckers, J. W., Van Duijn, C. M., and Stricker, B. H. C. (2004). Genetic polymorphisms and heart failure. Genet. Med. 6, 465-474.
4. Bossuyt, J., Ai, X., Moorman, J. R., Pogwizd, S. M., and Bers, D. M. (2005). Expression and phosphorylation of the Na-pump regulatory subunit phospholemman in heart failure. Circ. Res. 97, 558-565.
5. Brodde, O. E., Bruck, H., Leineweber, K., and Seyfarth, T. (2001). Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res. Cardiol. 96, 528-538.
6. Campbell, K. P., MacLennan, D. H., Jorgensen, A. O., and Mintzer, M. C. (1983). Purification and characterization of calsequestrin from canine cardiac sarcoplasmic reticulum and identification of the 53,000 dalton glycoprotein. J. Biol. Chem. 258, 1197-1204.
7. Conrady, A. O., Rudomanov, O. G., Zaharov, D. V., Iakovleva, O. I., Ovchinnicova, O. A., Vahrameeva, N. V., et al. (2005). Prospective study of the changes in left ventricular mass and geometry patterns in hypertensive patients During 5 years of follow-up. Circ. J. 69, 1374-1379.
8. Cook, S. A., Clerk, A., and Sugden, P. H. (2009). Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure? J. Mol. Cell. Cardiol. 46, 118-129.
9. Cozens, B., and Reithmeier, R. A. (1984). Size and shape of rabbit skeletal muscle calsequestrin. J. Biol. Chem. 259, 6248-6252.
10. Davie, S. A., Maglione, J. E., Manner, C. K., Young, D., Cardiff, R. D., MacLeod, C. L., et al. (2007). Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res. 16, 193-201.
11. Galindo, C. L., Skinner, M. A., Errami, M., Olson, L. D., Watson, D. A., Li, J., et al. (2009). Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC Physiol. 9:23. doi: 10.1186/1472-6793-9-23
12. Grubb, S. C., Maddatu, T. P., Bult, C. J., and Bogue, M. A. (2009). Mouse phenome database. Nucleic Acids Res. 37, D720-D730.
13. Jones, L. R., Suzuki, Y. J., Wang, W., Kobayashi, Y. M., Ramesh, V., Franzini-Armstrong, C., et al. (1998). Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J. Clin. Invest. 101, 1385-1393.
14. Knollmann, B. C. (2009). New roles of calsequestrin and triadin in cardiac muscle. J. Physiol. (Lond.) 587, 3081-3087.
15. Knollmann, B. C., Chopra, N., Hlaing, T., Akin, B., Yang, T., Ettensohn, K., et al. (2006). Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J. Clin. Invest. 116, 2510-2520.
16. Kunitomo, Y., and Terentyev, D. (2011). How to stop the fire? Control of Ca2+-induced Ca2+ release in cardiac muscle. J. Physiol. 589, 5899-5900.
17. Li, L., Desantiago, J., Chu, G., Kranias, E. G., and Bers, D. M. (2000). Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation. Am. J. Physiol. Heart Circ. Physiol. 278, H769-H779.
18. Liggett, S. B. (2000). Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 61, 167-173.
19. Linck, B., Bokník, P., Baba, H. A., Eschenhagen, T., Haverkamp, U., Jäckel, E., et al. (1998). Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle. J. Pharmacol. Exp. Ther. 286, 531-538.
20. Lum, C., Shesely, E. G., Potter, D. L., and Beierwaltes, W. H. (2004). Cardiovascular and renal phenotype in mice with one or two renin genes. Hypertension 43, 79-86.
21. MacLennan, D. H., and Wong, P. T. (1971). Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 68, 1231-1235.
22. Periasamy, M., and Huke, S. (2001). SERCA pump level is a critical determinant of Ca2+ homeostasis and cardiac contractility. J. Mol. Cell. Cardiol. 33, 1053-1063.
23. Port, J. D., and Bristow, M. R. (2001). Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J. Mol. Cell. Cardiol. 33, 887-905.
24. Roden, D. M., Johnson, J. A., Kimmel, S. E., Krauss, R. M., Medina, M. W., Shuldiner, A., et al. (2011). Cardiovascular pharmacogenomics. Circ. Res. 109, 807-820.
25. Sato, Y., Schmidt, A. G., Kiriazis, H., Hoit, B. D., and Kranias, E. G. (2003). Compensated hypertrophy of cardiac ventricles in aged transgenic FVB/N mice overexpressing calsequestrin. Mol. Cell. Biochem. 242, 19-25.
26. Shah, A. P., Siedlecka, U., Gandhi, A., Navaratnarajah, M., Abou Al-Saud, S., Yacoub, M. H., et al. (2010). Genetic background affects function and intracellular calcium regulation of mouse hearts. Cardiovasc. Res. 87, 683-693.
27. Shan, J., Kushnir, A., Betzenhauser, M. J., Reiken, S., Li, J., Lehnart, S. E., et al. (2010). Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J. Clin. Invest. 120, 4388-4398.
28. Song, L., Alcalai, R., Arad, M., Wolf, C. M., Toka, O., Conner, D. A., et al. (2007). Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J. Clin. Invest. 117, 1814-1823.
29. Terentyev, D., Kubalova, Z., Valle, G., Nori, A., Vedamoorthyrao, S., Terentyeva, R., et al. (2008). Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death. Biophys. J. 95, 2037-2048.
30. Terentyev, D., Viatchenko-Karpinski, S., Györke, I., Volpe, P., Williams, S. C., and Györke, S. (2003). Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: mechanism for hereditary arrhythmia. Proc. Natl. Acad. Sci. U.S.A. 100, 11759-11764.
31. Wang, Q., Hummler, E., Nussberger, J., Clément, S., Gabbiani, G., Brunner, H. R., et al. (2002). Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes. J. Am. Soc. Nephrol. 13, 1509-1516.